ImmunoBio Series 2025 - West Coast Edition 2

6th - 7th February 2025

San Diego, USA

Empowering Innovation, Transforming Cancer Care: Uniting Industry Leaders for Future Patient Success

Immerse yourself in the realm of cancer treatment and biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions. Anticipated as one of the largest industry-led meeting, this conference unites over 200 senior decision-makers in the biomarker and immune-oncology field, providing unparalleled insights. Attendees will gain actionable insights on the identification of cancer biomarkers and the development of ADC’s, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy shaping the future of immuno-oncology. The 2024 summit promises an exclusive opportunity for knowledge sharing and networking among industry leaders, pharma, biopharma and biotech companies, making a marked difference in patient outcomes.

Join us for this transformative event, where innovation meets collaboration, shaping the future of healthcare and biotechnology.


2nd Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference - West Coast Edition
10th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference - West Coast Edition




San Diego, USA